Ferriprox

Active Ingredient(s): Deferiprone
FDA Approved: * October 14, 2011
Pharm Company: * APOPHARMA INC
Category: Iron Chelator

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ferriprox Overview

Deferiprone (tradenames include Ferriprox) is a drug that chelates iron and is used to treat iron overload in thalassaemia major.[1] It was first approved for use in treating thalassaemia major in 1994[2] and had been licensed for use in Europe and Asia for many years while awaiting approval in Canada and the United States.[1] On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program.[3]...

Read more Ferriprox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deferiprone

Recent Ferriprox Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Ferriprox: (3 results)

Sorted by National Drug Code

• 52609-0006 Ferriprox 500 mg Oral Tablet by Apopharma USA, Inc.
• 52609-0007 Ferriprox 1000 mg Oral Tablet, Film Coated by Apopharma USA, Inc.
• 52609-4502 Ferriprox 100 mg/ml Oral Solution by Apo-pharma USA, Inc.

Other drugs which contain Deferiprone or a similar ingredient: (1 result)

• DEFERIPRONE

Related Ferriprox Topics: